Book an appointment with us, or search the directory to find the right lawyer for you directly through the app.
Find out more
Deal by Design
Welcome to this edition of Law Update, focusing on the evolving M&A landscape across the MENA region. With deal activity and value continuing to grow, the region is seeing increased investor interest alongside a changing regulatory environment.
This edition explores key legal and market developments affecting M&A transactions, including regulatory reforms, foreign investment, governance, due diligence and deal structuring across the region.
Partner, Head of Banking and Finance - Egypt
On 11 July 2024, Egypt’s Unified Insurance Law No. 155 of 2024 (the Unified Insurance Law) entered into force, marking a fundamental transformation of the nation’s insurance regulatory landscape. The Unified Insurance Law brought together four separate insurance legislations into a single, comprehensive framework and vested the Financial Regulatory Authority (FRA) with wide-ranging powers to licence, supervise, oversee, and regulate insurance activities and related professions.
One of the most significant developments introduced by the Unified Insurance Law is the formal inclusion of healthcare-related intermediaries, namely third-party administrators (TPAs) and health maintenance organisations (HMOs), within the insurance regulatory perimeter. This longstanding regulatory gap has now been addressed through the law itself and a series of implementing FRA decisions issued in 2024 and 2025.
Before the enactment of the Unified Insurance Law, medical insurance activities in Egypt were governed primarily by the now-repealed Insurance Supervision and Control Law No. 10 of 1981. This framework regulated insurance companies by offering medical coverage as a class of insurance, but did not expressly recognise specialised medical insurance companies or healthcare programme management entities as distinct regulated categories.
Consequently, TPAs and HMOs operated outside any insurance- or health insurance-specific regulatory framework. In the absence of a dedicated licensing regime, they were established as ordinary commercial companies under the Egyptian Companies Law No. 159 of 1981 (as amended) and were subject only to general corporate oversight by the General Authority for Investment and Free Zones. Their activities were largely governed by private contractual arrangements, with regulatory accountability resting primarily at the level of the licensed insurer.
Although licensed insurance companies remained fully regulated and liable to policyholders, regulators treated TPAs and HMOs indirectly, holding the insurer accountable while imposing no direct prudential, governance, or conduct requirements on the intermediaries themselves. This indirect oversight created legal uncertainty and increased operational risk within the healthcare insurance sector.
The Unified Insurance Law introduced a clear classification of insurance activities, expressly recognising medical insurance as a regulated class. Within this framework, the Unified Insurance Law enabled the FRA to regulate both risk-bearing medical insurance providers and non-risk-bearing healthcare intermediaries through tailored licensing and supervisory regimes.
Subsequent FRA decisions have operationalised this mandate by establishing distinct regulatory frameworks for TPAs and HMOs, reflecting their fundamentally different roles within the healthcare insurance value chain.
New regulatory framework for TPAs
Under the new regime, healthcare programme management companies, commonly referred to as TPAs, are formally recognised as a standalone regulated category for the first time. TPAs do not assume insurance risk. Instead, they undertake administrative and operational functions related to medical insurance policies, including claims management, medical approvals, network administration, and benefit coordination, acting on behalf of licensed insurers or managing self-funded healthcare programmes for employers and institutions.
The FRA regulations now require TPAs to meet certain requirements, including:
Licensing applications must include feasibility studies, detailed shareholder disclosures, and supporting documentation, and remain subject to FRA review and on-site inspection where required.
The FRA has stipulated that TPA companies are prohibited from:
New regulatory framework for HMOs
Specialised medical insurance companies, commonly known as HMOs, are regulated as risk-bearing entities under the Unified Insurance Law and related FRA decisions. Unlike TPAs, HMOs provide direct medical insurance coverage and assume underwriting risk.
Accordingly, HMOs are subject to more stringent prudential and operational requirements, including:
A key requirement for HMOs is that their shareholding structure must include financial institutions, holding no less than 25% of the share capital.
To facilitate an orderly transition to the new regime, the FRA introduced a temporary licensing regime for existing TPAs and HMOs. Entities must apply for a temporary license as part of their reconciliation process , allowing them to continue to operate while Failure to meet the prescribed compliance timelines set out under the Unified Insurance Law and the FRA Board of Directors’ decisions will result in revocation of the temporary licence.
Following the issuance of their temporary licences, TPAs and HMOs are required, pursuant to the FRA’s executive decisions, to prepare and submit relevant documentation to support the issuance of the final permanent licences. In this respect, TPAs and HMOs are granted a reconciliation period to complete reconciliation processes and ensure compliance.
Ever since the issuance of the Unified Insurance Law, the FRA has been regularly issuing new decisions and regulations with respect to TPAs and HMOs. These include a tailored guidebook for TPAs and detailed governance rules for insurance companies, including HMOs. Such companies must adhere to the stipulated frameworks and timeframes to ensure full compliance with the newly issued regulations.
Partner, Head of Banking and Finance - Egypt
The Unified Insurance Law marks a decisive shift from a contract-based, largely unregulated model to a formal and comprehensive regulatory regime for TPAs and HMOs in Egypt. Entities that previously operated solely under general corporate and investment laws are now firmly within the FRA’s supervisory scope.
While the new framework imposes significant compliance and governance obligations, it also delivers long-awaited legal clarity, strengthens consumer protection, and enhances market confidence. By consolidating regulations and aligning healthcare insurance intermediaries with international best practices, the law is expected to support sustainable sector growth, attract investment, and expand access to structured and innovative medical insurance solutions in Egypt.
From a legal standpoint, these regulations provide a cohesive framework aimed at addressing and managing uncertainty. From a practical perspective, however, certain aspects still require adjustment, given the novelty of the subject matter. The FRA, along with all relevant stakeholders, must work collaboratively to achieve their objectives, as the framework is a work in progress and has not yet been fully tested. Greater organisation and open channels of communication between the FRA and businesses are essential to ensure effective implementation and to achieve the goals envisaged under the new law and its accompanying decisions.
In practice, the FRA continues to face challenges in implementing the new framework, as its initial requirements have expanded to include additional documentation and compliance obligations. This evolution, while reflecting the FRA’s institutional learning and adaptability, has created uncertainty and a level of confusion during the transitional phase, with businesses at risk of losing clients as procedures are tested and refined.
This dynamic has, in effect, operated as a mechanism for filtering the Egyptian insurance market, distinguishing between entities capable of meeting regulatory standards and those unable or unwilling to do so. Although occasional regulatory inconsistencies arise, the broader reform effort remains a collective undertaking involving the FRA and all relevant stakeholders.
It is therefore imperative that the FRA ensures greater alignment and coordination throughout this process. Market participants should be permitted to continue operations without undue disruption, even as they adapt to evolving regulatory requirements. Enhanced coordination is particularly necessary to identify companies that satisfy solvency standards and to safeguard investors against risks stemming from previously absent procedures.
Ultimately, the objective of the Unified Insurance Law is not to obstruct legitimate business activities, but to reinforce market integrity and protect stakeholders in Egypt’s insurance sector.
Partner, Head of Banking and Finance - Egypt